Correspondence 0001628280-23-040357 from BIOLIFE SOLUTIONS INC (BLFS) (CIK 0000834365) (BLFS)
BIOLIFE SOLUTIONS INC (BLFS) (CIK 0000834365)
Date: Nov. 30, 2023 · CIK: 0000834365 · Accession: 0001628280-23-040357
AI Filing Summary & Sentiment
File numbers found in text: 333-275646
Letter
Document
BIOLIFE SOLUTIONS, INC.
3303 Monte Villa Parkway, Suite 310
Bothell, Washington, 98021
November 30, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: BioLife Solutions, Inc.
Registration Statement on Form S-3
File No. 333-275646
Request for Acceleration
Acceleration Request
Request Date: December 4, 2023
Request Time: 4:30 p.m. Eastern Time (or as soon thereafter as practicable)
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioLife Solutions, Inc. (the “Registrant”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-275646) to become effective at 4:30 p.m. Eastern Time on December 4, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes K&L Gates LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Michael A. Hedge at (949) 623-3519, or in his absence, Jason C. Dreibelbis at (949) 623-3543.
Sincerely,
BIOLIFE SOLUTIONS, INC.
Show Raw Text
CORRESP 1 filename1.htm Document BIOLIFE SOLUTIONS, INC. 3303 Monte Villa Parkway, Suite 310 Bothell, Washington, 98021 November 30, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: BioLife Solutions, Inc. Registration Statement on Form S-3 File No. 333-275646 Request for Acceleration Acceleration Request Request Date: December 4, 2023 Request Time: 4:30 p.m. Eastern Time (or as soon thereafter as practicable) Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, BioLife Solutions, Inc. (the “Registrant”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-275646) to become effective at 4:30 p.m. Eastern Time on December 4, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes K&L Gates LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. The Registrant requests that it be notified of such effectiveness by a telephone call to Michael A. Hedge at (949) 623-3519, or in his absence, Jason C. Dreibelbis at (949) 623-3543. Sincerely, BIOLIFE SOLUTIONS, INC. By: /s/ Roderick de Greef Roderick de Greef President and Chief Executive Officer (Principal Executive Officer) cc: Troy Wichterman, BioLife Solutions, Inc. Michael A. Hedge, K&L Gates LLP Jason C. Dreibelbis, K&L Gates LLP